Drug Topics
JULY 17, 2025
Jennifer Clements, PharmD, FCCP, FADCES, BCPS, CDCES, BCACP, BC-ADM, discusses how pharmacists can collaborate with providers to optimize insulin therapy.
Pharmacy Times
JULY 17, 2025
The FDA approves a prefilled syringe for the zoster vaccine recombinant, enhancing shingles vaccination convenience and effectiveness for adults 50 and older.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
JULY 17, 2025
News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy Journal Submission of Articles Events Virtual Events Total Pharmacy Solutions Summit Business Business Strategies Patient Services Pharmacy Inv
Pharmacy Times
JULY 17, 2025
An expert discusses how pharmacists can ensure completion of multidose pneumococcal vaccine series through electronic reminder systems, state immunization registries, scheduled follow-up appointments, and providing patients with printed vaccine cards for tracking purposes.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
JULY 17, 2025
Pharmacists play a key role in ensuring safe and effective insulin use by identifying common challenges, providing ongoing education, and supporting patient confidence through regular engagement.
Pharmacy Times
JULY 17, 2025
An expert discusses how pharmacists play a crucial role in managing tyrosine kinase inhibitor toxicities through proactive monitoring strategies, patient education about adverse effects such as myelosuppression and fluid retention, and early intervention protocols to maintain treatment adherence and quality of life.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Oswald's
JULY 17, 2025
As we age, maintaining our health and vitality becomes increasingly important. Dietary supplements can play a supportive role in this journey. As a pharmacist, I make supplement recommendations every day. These suggestions tend to be similar for many individuals. The nutrients essential for bone, nerve, and gut health can often be obtained through a healthy and diverse diet.
Drug Topics
JULY 17, 2025
News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy Journal Submission of Articles Events Virtual Events Total Pharmacy Solutions Summit Business Business Strategies Patient Services Pharmacy Inv
Pharmacy Times
JULY 17, 2025
News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice in Focus: Oncology Pharmacy Practice in Focus: Health Systems Pharmacy Careers All Publications About the Publications Author Submission Submit to
Drug Topics
JULY 17, 2025
News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy Journal Submission of Articles Events Virtual Events Total Pharmacy Solutions Summit Business Business Strategies Patient Services Pharmacy Inv
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
The Checkup by Singlecare
JULY 17, 2025
Many people with attention deficit hyperactivity disorder (ADHD) rely on a stimulant drug to stay focused and be able to function throughout the day. Vyvanse and Adderall are popular prescription drugs used to treat ADHD, and, in some cases, can help treat other conditions like binge eating disorder and narcolepsy. You might switch from one to another if there’s a drug shortage, you’re dealing with side effects, or what you’re using just isn’t working for you.
Pharmaceutical Commerce
JULY 17, 2025
In the third part of his Pharma Commerce video interview, Sean O’Hearen, founder and principal consultant at 1st Line Partners, recommends regulatory or verification mechanisms that can help safely legitimize online medicine procurement.
Pharmacy Times
JULY 17, 2025
News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice in Focus: Oncology Pharmacy Practice in Focus: Health Systems Pharmacy Careers All Publications About the Publications Author Submission Submit to
European Pharmaceutical Review
JULY 17, 2025
New research has shown that AI can improve the precision of patient selection for clinical trials. By choosing individuals who are most likely to benefit from treatment, the approach could help to reduce the cost of developing new medicines by streamlining clinical trials. Scientists tested their model on data for an Alzheimer’s drug. “Our AI model gives us a score to show how quickly each patient will progress towards Alzheimer’s disease.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
The Checkup by Singlecare
JULY 17, 2025
Your healthcare provider might prescribe Mounjaro or Farxiga to help manage Type 2 diabetes, especially when diet and exercise aren’t enough. Both medications help control blood sugar and may also support weight loss, reducing serious risks related to diabetes. Although Mounjaro and Farxiga treat similar problems, they belong to different drug classes and work in different ways.
Pharmacy Times
JULY 17, 2025
News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice in Focus: Oncology Pharmacy Practice in Focus: Health Systems Pharmacy Careers All Publications About the Publications Author Submission Submit to
Fuld
JULY 17, 2025
In a world where macroeconomic shocks, geopolitical shifts, and technology disruptions seem to unfold in increasingly compressed cycles, many leadership teams are discovering that agility is no longer a competitive advantage—it’s a requirement. Yet amid this turbulence, a small subset of companies consistently outmaneuver their peers. One common thread?
pharmaphorum
JULY 17, 2025
With the rise of advanced simulation and model-informed drug development (MIDD) techniques like digital twins, researchers can now transform their strategies by using models to duplicate biological systems.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT
JULY 17, 2025
Pop quiz: What’s Coca-Cola with cane sugar and ice cream made with natural dyes? Answer: Coca-Cola and ice cream. Getting Coca-Cola to use cane sugar rather than corn syrup and ice cream manufacturers to stop their use of synthetic dyes are the latest achievements trumpeted by the Make America Healthy Again movement as part of its quest to reform the U.S. food supply.
Fuld
JULY 17, 2025
Innovation rarely announces itself with a headline. More often, it appears at the margins—inside obscure academic journals, startup patents, or niche use cases in emerging markets. For companies seeking sustainable differentiation, developing an edge in identifying emerging technologies before they gain mainstream traction is no longer optional. It’s a strategic imperative.
STAT
JULY 17, 2025
After a decade-long rise in suicide rates among young Americans — and with depression diagnoses soaring in this age group during the pandemic — the U.S. surgeon general issued a report in 2021 warning about the “devastating” state of youth mental health. The American Psychological Association declared it a “crisis.
PharmTech
JULY 17, 2025
News All News Bio/Pharma News Publications All Publications PharmTech PharmTech Europe Resources Marketplace ICH Q9 Revision: A Comprehensive Resource on Quality Risk Management Peer-Reviewed Research PharmTech Products Pharma Insights Sponsored Podcasts Sponsored Videos Sponsored eBooks Whitepapers Webcasts Multimedia All Videos Ask the Expert Behind The Headlines Buy, Sell, Hold Drug Digest Videos Drug Solutions Podcast Peer Exchange Sexy Science Tech Talk Conference Conference Coverage Confer
Pharma Times
JULY 17, 2025
Subscribe Advertise About us Follow Follow Follow Follow GO Magazine PharmaTimes Magazine Archive Web Exclusives News Competitions Appointments Business Insights Webinars Thought Leadership Seaport Therapeutics begins phase 2b trial of GlyphAllo for major depression by John Pinching | 17th Jul 2025 | News First patient dosed in BUOY-1 study targeting MDD with or without anxious distress Seaport Therapeutics has dosed the first patient in its phase 2b BUOY-1 trial of GlyphAllo, a novel oral prodr
pharmaphorum
JULY 17, 2025
OpenEvidence has raised $210m to expand the capabilities of its physician decision-making tool and launch a new service offering 'PhD-level' research
Fierce Pharma
JULY 17, 2025
Taking a page from Eli Lilly and Novo Nordisk, who have launched online programs to sell their diabetes and obesity drugs directly to patients, Bristol Myers Squibb and Pfizer are doing the same with their mega-blockbuster blood thinner Eliquis.
pharmaphorum
JULY 17, 2025
AIs that detect spinal fractures during routine CT scans could help the NHS reduce hip fractures and other costly complications, says NICE.
Pharmaceutical Commerce
JULY 17, 2025
In the fourth part of his Pharma Commerce video interview, Murray Aitken, executive director, IQVIA Institute for Human Data Science, outlines what he anticipates for the biosimilar adoption curve in key markets moving forward.
Fuld
JULY 17, 2025
Whether assessing a market for entry, defending share, or planning for the next fiscal cycle, understanding who’s moving, how fast, and in what direction enables smarter, faster decisions. Yet “industry landscaping” often gets reduced to static quadrant models or outdated market reports. Sophisticated strategists know that mapping the competitive terrain requires more than a list of names.
Pharmacy Times
JULY 17, 2025
Once-weekly efsitora alfa shows promising hemoglobin A1C reduction in type 2 diabetes (T2D), simplifying insulin therapy and reducing injection frequency significantly.
pharmaphorum
JULY 17, 2025
EVERSANA has launched a new pharmacovigilance platform to answer the need for advanced analytics and AI in drug safety monitoring and risk management.
Pharmacy Times
JULY 17, 2025
An expert discusses how traditionally later-line therapies such as ponatinib and asciminib are now being reconsidered for earlier use, with asciminib approved for frontline treatment and ponatinib potentially used as second-line therapy for patients with specific mutations or comorbidities.
Pharmafile
JULY 17, 2025
Biogen and Stoke Therapeutics have shared encouraging new data for their experimental treatment, zorevunersen, which is being developed for Dravet syndrome – a rare, severe form of epilepsy. The results, presented at the European Paediatric Neurology Society Congress in Munich, Germany, showed that patients treated with zorevunersen experienced improvements in cognition and behaviour after a […] The post Biogen and Stoke report positive results for Dravet syndrome drug appeared first on Ph
The Checkup by Singlecare
JULY 17, 2025
If you have Type 2 diabetes , you may have heard about prescription drugs like Mounjaro or Jardiance. These medications are prescribed to help people lower their blood sugar levels and slow disease progression. Both Mounjaro and Jardiance are brand-name diabetes medications, but they belong to different drug classes and work in different ways to help control blood sugar.
Expert insights. Personalized for you.
Let's personalize your content